In the US, Exenatide (exenatide systemic) is a member of the drug class incretin mimetics and is used to treat Diabetes, Type 2.
US matches:
- Exenatide
- Exenatide Subcutaneous
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
A10BX04
CAS registry number (Chemical Abstracts Service)
0141758-74-9
Chemical Formula
C184-H282-N50-O60-S
Molecular Weight
4186
Therapeutic Category
Antidiabetic agent, incretin-mimetic, glucagon-like peptide-1 (GLP-1) agonist
Chemical Names
Exendin 4 (USAN)
L-Histidylglycyl-L-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-aspartyl-L-leucyl-L-seryl-L-lysyl-L-glutaminyl-L-methionyl-L-glutamyl-L-glutamyl-L-glutamyl-L-alanyl-L-valyl-L-arginyl-L-leucyl-L-phenylalanyl-L-isoleucyl-L-glutamyl-L-trypto (WHO)
Foreign Names
- Exenatidum (Latin)
- Exenatid (German)
- Exénatide (French)
- Exenatida (Spanish)
Generic Names
- Exenatide (OS: USAN, BAN)
- AC 2993 LAR (IS: Amylin)
- AC002993 (IS: Amylin)
- AC2993 (IS: Amylin)
- AC-2993 (IS: Amylin)
- AC2993A (IS: Amylin)
- Exendin-4 (IS: Heloderma suspectum)
- Exendin-4 (IS: synthetic)
- LY2148568 (IS: Amylin)
- Medisorb (IS)
Brand Names
- Byetta
Amylin, United States; Eli Lilly, United Kingdom; Eli Lilly, Netherlands; Eli Lilly NL B.V., Luxembourg; Lilly, Argentina; Lilly, Austria; Lilly, Australia; Lilly, Belgium; Lilly, Switzerland; Lilly, Germany; Lilly, Denmark; Lilly, Finland; Lilly, France; Lilly, Greece; Lilly, Ireland; Lilly, Italy; Lilly, Norway; Lilly, Slovenia; Lilly, Slovakia; Lilly, United States - BYETTA
Lilly, Sweden
International Drug Name Search
Glossary
BAN | British Approved Name |
IS | Inofficial Synonym |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment